{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidriec6xuymzb5nv6kgrupsq3uagynamxubsrmjziecldxsgq3g6m",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhusttj3f6s2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigp65etpkcttzs5w7esncr6jdzap6v4maglpar22rngqmmakazbyy"
    },
    "mimeType": "image/jpeg",
    "size": 53571
  },
  "path": "/2026/03/25/eli-lilly-cancer-drug-pipeline-fueled-loxo-oncology-jacob-van-naarden/?utm_campaign=rss",
  "publishedAt": "2026-03-25T08:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Pharma",
    "biotechnology",
    "Cancer",
    "Eli Lilly",
    "Pharmaceuticals",
    "STAT+",
    "STAT Summit"
  ],
  "textContent": "How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward.",
  "title": "STAT+: How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward",
  "updatedAt": "2026-03-24T23:27:23.000Z"
}